Skip to content
Menu
Network
Sub-Menu
Browse by Subject
Browse by Publisher
Join the Network
Get Started
Subscribe
Support
Contact
Search
Close
Enter Search Terms
Search
Beth Ashbridge
ID:
1b83f0dd-2619-30fb-68c4
/
Unclaimed
/
Organization:
Goodwin Procter
Published Works
36 articles
Xbrane Biopharma Plans to Continue Phase III Trial of its Xlucane® (Ranibizumab) Biosimilar Product
Big Molecule Watch ·
April 23, 2020
cite
Previous
1
...
7
8
Next
